Christopher Yu-Tai Yen

Title: Innovations by Christopher Yu-Tai Yen

Introduction

Christopher Yu-Tai Yen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of drug delivery systems, particularly in treating brain and heart conditions. With a total of 2 patents, his work showcases innovative approaches to medical therapies.

Latest Patents

One of his latest patents is a reloadable hydrogel system for treating brain conditions. This drug delivery system is designed to deliver a pegylated therapeutic agent to the brain. It may comprise an antibody that binds polyethylene glycol (PEG), embedded in a hydrogel made of biodegradable polymers. Up to 60% of these polymers can contain inter-chain or intra-chain covalent crosslinks. The system can deliver about 1-2 µg of the antibody per µl of the hydrogel. Another significant patent involves a reloadable hydrogel system comprising an anti-PEG antibody for treating myocardial infarction. This system also utilizes a hydrogel with biodegradable polymers to deliver pegylated therapeutic agents to the heart.

Career Highlights

Christopher Yu-Tai Yen is affiliated with Academia Sinica, a prestigious research institution in Taiwan. His work at this institution has allowed him to focus on innovative drug delivery systems that have the potential to improve patient outcomes in critical medical conditions.

Collaborations

He has collaborated with notable colleagues such as Patrick C H Hsieh and David Lundy, contributing to the advancement of research in his field.

Conclusion

Christopher Yu-Tai Yen's innovative work in drug delivery systems highlights his commitment to advancing medical therapies. His patents reflect a deep understanding of biomedicine and a dedication to improving health outcomes.